{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:53:08Z","timestamp":1791503588161,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Abiomed Europe GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40119-025-00404-w","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T15:56:52Z","timestamp":1743350212000},"page":"183-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6330-0591","authenticated-orcid":false,"given":"Carla","family":"Rognoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Ardito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"La Fauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mara","family":"Scandroglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"404_CR1","unstructured":"Kosaraju A, Pendela VS, Hai O. Cardiogenic Shock. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Dec 28]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482255\/. Accessed 18 Mar 2025"},{"key":"404_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000590","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3: e000590.","journal-title":"J Am Heart Assoc"},{"key":"404_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2022.04.049","volume":"80","author":"NK Kapur","year":"2022","unstructured":"Kapur NK, Kanwar M, Sinha SS, Thayer KL, Garan AR, Hernandez-Montfort J, et al. Criteria for defining stages of cardiogenic shock severity. J Am Coll Cardiol. 2022;80:185\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"404_CR4","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"404_CR5","doi-asserted-by":"publisher","first-page":"131418","DOI":"10.1016\/j.ijcard.2023.131418","volume":"396","author":"M Pieri","year":"2023","unstructured":"Pieri M, Dndria Ursoleo J, Nardelli P, Ortalda A, Ajello S, Delrio S, et al. Temporary mechanical circulatory support with Impella in cardiac surgery: a systematic review. Int J Cardiol. 2023;396:131418.","journal-title":"Int J Cardiol"},{"key":"404_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/MAT.0000000000001931","volume":"69","author":"WG Cohen","year":"2023","unstructured":"Cohen WG, Rekhtman D, Iyengar A, Shin M, Ibrahim M, Bermudez C, et al. Extended support with the Impella 5.5: transplant, ECMO, and complications. ASAIO J. 2023;69:642\u20138.","journal-title":"ASAIO J"},{"key":"404_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2018.03.024","volume":"202","author":"WW O\u2019Neill","year":"2018","unstructured":"O\u2019Neill WW, Grines C, Schreiber T, Moses J, Maini B, Dixon SR, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. 2018;202:33\u20138.","journal-title":"Am Heart J"},{"key":"404_CR8","first-page":"1173","volume":"93","author":"MB Basir","year":"2019","unstructured":"Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, et al. Improved outcomes associated with the use of shock protocols: updates from the national cardiogenic shock initiative. Catheter Cardiovasc Interv. 2019;93:1173\u201383.","journal-title":"Catheter Cardiovasc Interv"},{"key":"404_CR9","doi-asserted-by":"publisher","first-page":"1379199","DOI":"10.3389\/fcvm.2024.1379199","volume":"11","author":"M Pieri","year":"2024","unstructured":"Pieri M, Ortalda A, Altizio S, Bertoglio L, Nardelli P, Fominskiy E, et al. Prolonged Impella 5.0\/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center. Front Cardiovasc Med. 2024;11:1379199.","journal-title":"Front Cardiovasc Med"},{"key":"404_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","volume":"390","author":"JE M\u00f8ller","year":"2024","unstructured":"M\u00f8ller JE, Engstr\u00f8m T, Jensen LO, Eiskj\u00e6r H, Mangner N, Polzin A, et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med. 2024;390:1382\u201393.","journal-title":"N Engl J Med"},{"key":"404_CR11","unstructured":"Regulation on Health Technology Assessment - European Commission [Internet]. 2024 [cited 2024 Aug 6]. Available from: https:\/\/health.ec.europa.eu\/health-technology-assessment\/regulation-health-technology-assessment_en. Accessed 18 Mar 2025"},{"key":"404_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17434440.2023.2192868","volume":"20","author":"R Tarricone","year":"2023","unstructured":"Tarricone R, Banks H, Ciani O, Brouwer W, Drummond MF, Leidl R, et al. An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations. Expert Rev Med Devices. 2023;20:259\u201371.","journal-title":"Expert Rev Med Devices"},{"key":"404_CR13","unstructured":"Salute M della. Il Programma nazionale di HTA dei dispositivi medici [Internet]. [cited 2024 Sep 27]. Available from: https:\/\/www.salute.gov.it\/portale\/dispositiviMedici\/dettaglioContenutiDispositiviMedici.jsp?lingua=italiano&id=5201&area=dispositivi-medici&menu=tecnologie. Accessed 18 Mar 2025"},{"key":"404_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.healun.2009.02.015","volume":"28","author":"LW Stevenson","year":"2009","unstructured":"Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535\u201341.","journal-title":"J Heart Lung Transplant"},{"key":"404_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force. Value Health. 2022;25:10\u201331.","journal-title":"Value Health"},{"key":"404_CR16","first-page":"158","volume":"10","author":"V Ardito","year":"2023","unstructured":"Ardito V, Sarucanian L, Rognoni C, Pieri M, Scandroglio AM, Tarricone R. Impella versus VA-ECMO for patients with cardiogenic shock: comprehensive systematic literature review and meta-analyses. J Cardiovasc Dev Dis. 2023;10:158.","journal-title":"J Cardiovasc Dev Dis"},{"key":"404_CR17","unstructured":"Tavole di mortalit\u00e0 [Internet]. [cited 2020 May 4]. Available from: http:\/\/dati.istat.it\/Index.aspx?DataSetCode=DCIS_MORTALITA1. Accessed 18 Mar 2025"},{"key":"404_CR18","unstructured":"PE Guidelines Around The World: Italy [Internet]. [cited 2020 May 4]. Available from: https:\/\/tools.ispor.org\/PEguidelines\/countrydet.asp?c=13&t=4. Accessed 18 Mar 2025"},{"key":"404_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3111\/13696998.2012.762004","volume":"16","author":"JB Roos","year":"2013","unstructured":"Roos JB, Doshi SN, Konorza T, Palacios I, Schreiber T, Borisenko OV, et al. The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspective. J Med Econ. 2013;16:381\u201390.","journal-title":"J Med Econ"},{"key":"404_CR20","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/ndt\/gfq780","volume":"26","author":"M Haller","year":"2011","unstructured":"Haller M, Gutjahr G, Kramar R, Harnoncourt F, Oberbauer R. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant. 2011;26:2988\u201395.","journal-title":"Nephrol Dial Transplant"},{"key":"404_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00270-021-03050-6","volume":"45","author":"JB Pietzsch","year":"2022","unstructured":"Pietzsch JB, Geisler BP, Iken AR, van Wijck IPS, Holewijn S, Reijnen MMPJ. Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease in the Netherlands and Germany. Cardiovasc Intervent Radiol. 2022;45:298\u2013305.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"404_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1471-2377-12-137","volume":"12","author":"G Fattore","year":"2012","unstructured":"Fattore G, Torbica A, Susi A, Giovanni A, Benelli G, Gozzo M, et al. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 2012;12:137.","journal-title":"BMC Neurol"},{"key":"404_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/pds.5152","volume":"30","author":"Y Ingrasciotta","year":"2021","unstructured":"Ingrasciotta Y, Sultana J, Formica D, Ientile V, Aiello A, Chinellato A, et al. Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents. Pharmacoepidemiol Drug Saf. 2021;30:65\u201377. https:\/\/doi.org\/10.1002\/pds.5152.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"404_CR24","unstructured":"Chieffo A, Ancona MB, Burzotta F, Pazzanese V, Briguori C, Trani C, et al. Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry [Internet]. [cited 2024 Sep 9]. Available from: https:\/\/eurointervention.pcronline.com\/article\/observational-multicenter-registry-of-patients-treated-with-impella-mechanical-circulatory-support-device-in-italy-the-imp-it-registry. Accessed 18 Mar 2025"},{"key":"404_CR25","doi-asserted-by":"publisher","unstructured":"Messori A, Santarlasci B, Trippoli S. Guadagno di sopravvivenza dei nuovi farmaci. Pharmacoeconomics-Ital-Res-Articles [Internet]. 2004 [cited 2021 Jul 22];6:95\u2013104. https:\/\/doi.org\/10.1007\/BF03320627","DOI":"10.1007\/BF03320627"},{"key":"404_CR26","doi-asserted-by":"publisher","unstructured":"Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia | SpringerLink [Internet]. [cited 2021 Jul 22]. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/BF03320660","DOI":"10.1007\/BF03320660"},{"key":"404_CR27","doi-asserted-by":"crossref","unstructured":"Guyader AL, Pernot M, Delmas C, Roze S, Fau I, Flecher E, et al. <p>Budget Impact Associated with the Introduction of the Impella 5.0&reg; Mechanical Circulatory Support Device for Cardiogenic Shock in France<\/p>. CEOR [Internet]. 2021 [cited 2023 Dec 31];13:53\u201363. Available from: https:\/\/www.dovepress.com\/budget-impact-associated-with-the-introduction-of-the-impella-50reg-me-peer-reviewed-fulltext-article-CEOR. Accessed 18 Mar 2025","DOI":"10.2147\/CEOR.S278269"},{"key":"404_CR28","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.carrev.2020.05.042","volume":"21","author":"A Lemor","year":"2020","unstructured":"Lemor A, Hosseini Dehkordi SH, Basir MB, Villablanca PA, Jain T, Koenig GC, et al. Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock. Cardiovasc Revasc Med. 2020;21:1465\u201371.","journal-title":"Cardiovasc Revasc Med"},{"key":"404_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hec.3468","volume":"26 Suppl 1","author":"R Tarricone","year":"2017","unstructured":"Tarricone R, Torbica A, Drummond M, MedtecHTA Project Group. Key recommendations from the MedtecHTA project. Health Econ. 2017;26 Suppl 1:145\u201352.","journal-title":"Health Econ"},{"key":"404_CR30","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pds.4297","volume":"26","author":"ML Berger","year":"2017","unstructured":"Berger ML, Sox H, Willke RJ, Brixner DL, Eichler H-G, Goettsch W, et al. Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Pharmacoepidemiol Drug Saf. 2017;26:1033\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"404_CR31","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jacc.2022.01.037","volume":"79","author":"N Mihatov","year":"2022","unstructured":"Mihatov N, Mosarla RC, Kirtane AJ, Parikh SA, Rosenfield K, Chen S, et al. Outcomes associated with peripheral artery disease in myocardial infarction with cardiogenic shock. J Am Coll Cardiol. 2022;79:1223\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"404_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/hec.3471","volume":"26","author":"R Tarricone","year":"2017","unstructured":"Tarricone R, Callea G, Ogorevc M, Prevolnik RV. Improving the methods for the economic evaluation of medical devices. Health Econ. 2017;26(Suppl 1):70\u201392.","journal-title":"Health Econ"},{"key":"404_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078358","volume":"14","author":"V Ardito","year":"2024","unstructured":"Ardito V, Rognoni C, Pieri M, Barbone A, Briguori C, Cigala E, et al. Impella versus VA-ECMO for the treatment of patients with cardiogenic shock: the Impella Network Project - observational study protocol for cost-effectiveness and budget impact analyses. BMJ Open. 2024;14: e078358.","journal-title":"BMJ Open"},{"key":"404_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1524-4733.2008.00476_1.x","volume":"12","author":"M Drummond","year":"2009","unstructured":"Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs\u2013same or different? Value Health. 2009;12:402\u20134.","journal-title":"Value Health"}],"updated-by":[{"DOI":"10.1007\/s40119-025-00433-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000}}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00404-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-025-00404-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00404-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:32:17Z","timestamp":1759174337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-025-00404-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1007\/s40119-025-00404-w","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40119-025-00433-5","URL":"https:\/\/doi.org\/10.1007\/s40119-025-00433-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Carla Rognoni, Vittoria Ardito, Dario La Fauci, Marina Pieri, Anna Mara Scandroglio, and Rosanna Tarricone declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethics approval and informed consent were not needed for this study because the data used for the analyses were derived exclusively from studies published in the literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}